Taro Pharmaceutical Industries Ltd. (TARO)
Company Info
IL0010827181
001082718
Apr 1, 1993
Highlights
$1.62B
$1.43
30.05
$164.94M
$87.39M
$18.06M
$40.45 - $43.03
$43.00
0.91%
3.20
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Taro Pharmaceutical Industries Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
TARO
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
4.01%
1.13%
9.82%
22.80%
12.93%
11.26%
Monthly Returns
The table below presents the monthly returns of TARO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 3.04% | -2.28% | 0.64% | 0.33% | 0.80% | 2.85% | |||||||
| 2023 | 2.69% | 1.34% | -19.52% | 3.62% | 46.47% | 2.76% | -3.64% | 8.40% | -4.82% | -9.94% | 6.01% | 16.06% | 43.87% |
| 2022 | -6.57% | 4.34% | -11.44% | -9.27% | -6.70% | -1.26% | -1.30% | -5.69% | -10.93% | -0.17% | 0.74% | -3.68% | -42.05% |
| 2021 | 1.80% | -4.34% | 3.15% | 0.37% | -4.05% | 1.32% | -1.06% | -4.75% | -6.18% | -12.67% | -4.19% | -5.88% | -31.75% |
| 2020 | -8.26% | -16.54% | -9.10% | 12.92% | -1.40% | -2.42% | -2.23% | -5.85% | -10.39% | 6.89% | 20.42% | 3.99% | -16.50% |
| 2019 | 12.41% | 7.60% | 5.59% | -0.63% | -13.43% | -8.13% | -5.44% | -4.84% | -1.83% | 7.14% | 19.68% | -9.12% | 3.89% |
| 2018 | -2.88% | -3.48% | 0.60% | 3.28% | 16.66% | -2.76% | -2.96% | -5.90% | -6.95% | 1.23% | 8.45% | -10.14% | -7.39% |
| 2017 | -0.74% | 14.76% | -2.74% | 0.20% | -8.76% | 5.11% | 2.03% | -8.30% | 7.49% | -0.24% | -4.55% | -2.41% | -0.53% |
| 2016 | -5.66% | -0.62% | -1.13% | -2.45% | 4.57% | -0.36% | -3.87% | -9.55% | -12.71% | -8.14% | 0.64% | 3.04% | -31.89% |
| 2015 | 12.36% | -9.27% | -6.64% | -0.30% | 5.75% | -3.37% | -3.02% | -4.13% | 6.95% | 1.63% | -0.27% | 6.71% | 4.29% |
| 2014 | 3.09% | 9.46% | -0.55% | 1.20% | -5.15% | 31.63% | 0.73% | 14.09% | -4.53% | 5.25% | -11.39% | 3.28% | 49.84% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TARO is 66, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Taro Pharmaceutical Industries Ltd. (TARO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Taro Pharmaceutical Industries Ltd. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.86 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.19% |
Monthly Dividends
The table displays the monthly dividend distributions for Taro Pharmaceutical Industries Ltd.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $12.86 | $12.86 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Taro Pharmaceutical Industries Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Taro Pharmaceutical Industries Ltd. was 92.03%, occurring on Apr 30, 2007. Recovery took 1581 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.03% | Dec 3, 2003 | 856 | Apr 30, 2007 | 1581 | Sep 26, 2013 | 2437 |
| -84.66% | Feb 6, 2015 | 2049 | Mar 28, 2023 | — | — | — |
| -67.02% | Feb 3, 1997 | 396 | Aug 31, 1998 | 223 | Jul 23, 1999 | 619 |
| -55.46% | Jul 20, 2001 | 193 | May 1, 2002 | 259 | May 12, 2003 | 452 |
| -54.38% | Oct 19, 1993 | 149 | May 24, 1994 | 677 | Jan 30, 1997 | 826 |
Volatility
Volatility Chart
The current Taro Pharmaceutical Industries Ltd. volatility is 1.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Taro Pharmaceutical Industries Ltd. compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for TARO in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, TARO has a PE value of 30.0. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for TARO in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, TARO has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Taro Pharmaceutical Industries Ltd..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |